본문으로 건너뛰기
← 뒤로

Anti-cancer Potential of Scopoletin Derivatives Across Diverse Cancer Cell Lines: A Comprehensive Review.

1/5 보강
Current drug discovery technologies 2026 Vol.23(1) p. e15701638379522
Retraction 확인
출처

Karayat M, Kaushik N, Paliwal D, Chaudhary S

📝 환자 설명용 한 줄

Scopoletin, a naturally occurring coumarin derivative, has garnered significant attention for its diverse pharmacological properties, including potent anticancer activity.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Karayat M, Kaushik N, et al. (2026). Anti-cancer Potential of Scopoletin Derivatives Across Diverse Cancer Cell Lines: A Comprehensive Review.. Current drug discovery technologies, 23(1), e15701638379522. https://doi.org/10.2174/0115701638379522250412162643
MLA Karayat M, et al.. "Anti-cancer Potential of Scopoletin Derivatives Across Diverse Cancer Cell Lines: A Comprehensive Review.." Current drug discovery technologies, vol. 23, no. 1, 2026, pp. e15701638379522.
PMID 40277114

Abstract

Scopoletin, a naturally occurring coumarin derivative, has garnered significant attention for its diverse pharmacological properties, including potent anticancer activity. This review provides a comprehensive examination of scopoletin's anticancer effects across a wide range of tumor cell lines. The paper explores its modulation of apoptotic pathways, inhibition concentration (IC) of cancer cell proliferation, and suppression of metastasis and angiogenesis. Additionally, the review discusses the role of scopoletin in regulating oxidative stress, inflammation, and cell cycle arrest in cancer cells. A detailed analysis of and studies highlights its efficacy, specificity, and potential for synergistic effects when used in combination with conventional chemotherapeutics. Hence, this comprehensive review aims to provide a foundation for future research and development of scopoletin as a promising anticancer agent.

MeSH Terms

Humans; Scopoletin; Neoplasms; Apoptosis; Cell Proliferation; Animals; Antineoplastic Agents; Cell Line, Tumor; Oxidative Stress; Cell Cycle Checkpoints